TAK-861 Shows Promise in Phase 2b Narcolepsy Type 1 Trial
TAK-861 demonstrated significant and sustained improvements in the treatment of narcolepsy type 1 in a phase 2b clinical trial.
Source: sleepreviewmag.com
Narcolepsy Type News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Narcolepsy Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Narcolepsy Type Today - Breaking & Trending Today
Alkermes plc: Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
- Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - -
Source: finanznachrichten.de
Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says - Alkermes (NASDAQ:ALKS)
ALKS 2680 reports positive results in narcolepsy & idiopathic hypersomnia study. Statistically significant improvements in sleep latency were observed across all doses tested. Phase 2 study for NT2 patients is planned for 2nd half of 2024. Jefferies raises price target & probability of success for ALKS-2680.
Source: benzinga.com
Psychiatry in the News: February 2024
Here are some updates from the world of psychiatry throughout the month of February.
Source: psychiatrictimes.com
Essen Bakery offers up sweet treats to aid with Rare Disease Day – Metro US
Essen Bakery owner Tova du Plessis recently took to social media to document her struggle and recent diagnosis of Narcolepsy Type 1. She has been struggling with the rare disease for 14 months, and according to her, that time has been “debilitating”, making it difficult to run the bakery and oversee the brand’s expansion to […]
Source: metro.us